In RCC, PI3K overexpression has been proven to be crucial for tumour progression, and activation of PI3K protein is significantly related to the shortening of the survival time (Elfiky et al., 2011; Cheng et al., 2013). Here, PIK3CD is linked to renal cell carcinoma.